$RGNX (REGENXBIO) — 8-K: REGENXBIO appoints Greg Ciongoli to Board as two directors retire

REGENXBIO Inc. appointed Greg Ciongoli to its Board of Directors, effective August 25, 2026. Concurrently, Jerry Karabelas, Ph.D., an independent director since 2015, and Jean Bennett, M.D., Ph.D., an independent director since 2021, are retiring from the Board. Mr. Ciongoli is Founder and Managing Partner of Adiumentum Capital Management and previously spent over 16 years at The Baupost Group, where he served as Partner, Public Group Investing. The Board changes come as REGENXBIO prepares to become a global commercial organization with multiple upcoming catalysts across its late-stage gene therapy pipeline.

REGENXBIO Inc. appointed Greg Ciongoli to its Board of Directors, effective August 25, 2026. Concurrently, Jerry Karabelas, Ph.D., an independent director since 2015, and Jean Bennett, M.D., Ph.D., an independent director since 2021, are retiring from the Board. Mr. Ciongoli is Founder and Managing Partner of Adiumentum Capital Management and previously spent over 16 years at The Baupost Group, where he served as Partner, Public Group Investing. The Board changes come as REGENXBIO prepares to become a global commercial organization with multiple upcoming catalysts across its late-stage gene therapy pipeline.